Cognios Beta Neutral Large Cap Fund’s Edwards Lifesciences EW Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.54M	Buy	+52,329	New	+$2.44M	0.89%	38

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cognios Beta Neutral Large Cap Fund's EW Position: Q2 2018 in Review

Cognios Beta Neutral Large Cap Fund opened a new position in Edwards Lifesciences (EW) in Q2 2018: 52,329 shares worth $2.54M. The stake represents 0.89% of the portfolio and ranks #38 among its holdings.

838 funds tracked by Wall St. Rank hold EW as of Q2 2018.

Cognios Beta Neutral Large Cap Fund held 52,329 shares of Edwards Lifesciences worth $2.54M as of Q2 2018.
Edwards Lifesciences was a new Cognios Beta Neutral Large Cap Fund position in Q2 2018.
Edwards Lifesciences made up 0.89% of Cognios Beta Neutral Large Cap Fund's portfolio in Q2 2018, its #38 holding.
838 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q2 2018, filed 1 Aug 2018.